FIELD: pharmaceutical industry, medicine.
SUBSTANCE: method relates to composition containing estrogen as the first active ingredient in amount sufficient to treatment of diseases, disorders, and symptoms associated with deficit of endogen estrogen levels in women; and drospyrenon as the second ingredient in amount sufficient to endometrium protection from unfavorable estrogen effects. Methods for treatment also are disclosed. Preparations of present invention are useful in combination therapy for continuous, subsequent or intermittent administration.
EFFECT: method for replacement hormonotherapy in women of improved efficiency.
46 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DROSPIRENONE FOR HORMONAL REPLACEMENT THERAPY | 2005 |
|
RU2402331C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING TETRAHYDROFOLIC ACID | 2007 |
|
RU2479306C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING TETRAHYDROPHOLIC ACID | 2012 |
|
RU2624236C2 |
| METHOD FOR APPLYING HORMONE COMPOSITION CONTAINING A COMBINATION OF ESTROGEN AND PROGESTAGEN | 1997 |
|
RU2274450C2 |
| METHOD OF TREATING BENIGN HYPERPLASTIC PROCESSES OF FEMALE REPRODUCTIVE SYSTEM | 2011 |
|
RU2471485C1 |
| METHOD FOR TREATING CLIMACTERIC DISORDERS IN WOMEN EITHER DURING OR AFTER MENOPAUSE | 2001 |
|
RU2268035C2 |
| PHYTOESTROGEN COMPOSITIONS FOR PREVENTING OR TREATING MENOPAUSE-RELATED SYMPTOMS | 2008 |
|
RU2491926C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN | 2007 |
|
RU2379043C2 |
| BAZEDOXIFENE TREATMENT SCHEDULE | 2003 |
|
RU2355397C2 |
| INTERRUPTED HORMONE-SUBSTITUTION THERAPY WITH LOW ESTROGEN DOSAGES | 2000 |
|
RU2245713C2 |
